nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—ABCB1—ulcerative colitis	0.269	1	CbGaD
Boceprevir—CYP3A4—Budesonide—ulcerative colitis	0.0367	0.114	CbGbCtD
Boceprevir—CYP3A5—Sulfasalazine—ulcerative colitis	0.0318	0.0987	CbGbCtD
Boceprevir—ABCB1—Methylprednisolone—ulcerative colitis	0.0273	0.0848	CbGbCtD
Boceprevir—CYP3A5—Hydrocortisone—ulcerative colitis	0.0255	0.0792	CbGbCtD
Boceprevir—ABCB1—Betamethasone—ulcerative colitis	0.0178	0.0551	CbGbCtD
Boceprevir—ABCB1—Prednisolone—ulcerative colitis	0.0175	0.0544	CbGbCtD
Boceprevir—ABCB1—Hydrocortisone—ulcerative colitis	0.0166	0.0516	CbGbCtD
Boceprevir—ABCB1—Prednisone—ulcerative colitis	0.0166	0.0514	CbGbCtD
Boceprevir—CYP3A4—Methylprednisolone—ulcerative colitis	0.0164	0.0508	CbGbCtD
Boceprevir—CYP3A4—Nicotine—ulcerative colitis	0.016	0.0495	CbGbCtD
Boceprevir—CYP3A5—Dexamethasone—ulcerative colitis	0.0159	0.0493	CbGbCtD
Boceprevir—CYP3A4—Cholecalciferol—ulcerative colitis	0.0143	0.0444	CbGbCtD
Boceprevir—CYP3A4—Triamcinolone—ulcerative colitis	0.0124	0.0385	CbGbCtD
Boceprevir—CYP3A4—Betamethasone—ulcerative colitis	0.0106	0.033	CbGbCtD
Boceprevir—CYP3A4—Prednisolone—ulcerative colitis	0.0105	0.0326	CbGbCtD
Boceprevir—ABCB1—Dexamethasone—ulcerative colitis	0.0103	0.0321	CbGbCtD
Boceprevir—CYP3A4—Hydrocortisone—ulcerative colitis	0.00996	0.0309	CbGbCtD
Boceprevir—CYP3A4—Prednisone—ulcerative colitis	0.00992	0.0308	CbGbCtD
Boceprevir—CYP3A4—Dexamethasone—ulcerative colitis	0.00619	0.0192	CbGbCtD
Boceprevir—CMA1—smooth muscle tissue—ulcerative colitis	0.00444	0.0817	CbGeAlD
Boceprevir—CTSL—epithelium—ulcerative colitis	0.00394	0.0726	CbGeAlD
Boceprevir—CTSL—smooth muscle tissue—ulcerative colitis	0.0038	0.0699	CbGeAlD
Boceprevir—CTSV—lymphoid tissue—ulcerative colitis	0.00372	0.0684	CbGeAlD
Boceprevir—CMA1—lymphoid tissue—ulcerative colitis	0.00355	0.0653	CbGeAlD
Boceprevir—CMA1—digestive system—ulcerative colitis	0.00351	0.0645	CbGeAlD
Boceprevir—CTSL—lymphoid tissue—ulcerative colitis	0.00304	0.0559	CbGeAlD
Boceprevir—CTSL—digestive system—ulcerative colitis	0.003	0.0552	CbGeAlD
Boceprevir—CTSK—smooth muscle tissue—ulcerative colitis	0.00286	0.0527	CbGeAlD
Boceprevir—CMA1—liver—ulcerative colitis	0.00261	0.0481	CbGeAlD
Boceprevir—CTSS—smooth muscle tissue—ulcerative colitis	0.00251	0.0462	CbGeAlD
Boceprevir—CTSK—lymphoid tissue—ulcerative colitis	0.00229	0.0421	CbGeAlD
Boceprevir—CTSK—digestive system—ulcerative colitis	0.00226	0.0416	CbGeAlD
Boceprevir—CTSL—liver—ulcerative colitis	0.00223	0.0411	CbGeAlD
Boceprevir—CTSS—lymphoid tissue—ulcerative colitis	0.002	0.0369	CbGeAlD
Boceprevir—CTSS—digestive system—ulcerative colitis	0.00198	0.0364	CbGeAlD
Boceprevir—Telaprevir—ALB—ulcerative colitis	0.00197	0.512	CrCbGaD
Boceprevir—Telaprevir—ABCB1—ulcerative colitis	0.00188	0.488	CrCbGaD
Boceprevir—CTSL—Carbidopa—Mesalazine—ulcerative colitis	0.00186	0.355	CbGdCrCtD
Boceprevir—CTSK—liver—ulcerative colitis	0.00168	0.031	CbGeAlD
Boceprevir—CTSS—liver—ulcerative colitis	0.00148	0.0272	CbGeAlD
Boceprevir—CYP3A5—digestive system—ulcerative colitis	0.000658	0.0121	CbGeAlD
Boceprevir—CYP3A4—digestive system—ulcerative colitis	0.000493	0.00908	CbGeAlD
Boceprevir—CYP3A5—liver—ulcerative colitis	0.00049	0.00902	CbGeAlD
Boceprevir—ABCB1—epithelium—ulcerative colitis	0.000459	0.00845	CbGeAlD
Boceprevir—CYP3A4—liver—ulcerative colitis	0.000368	0.00677	CbGeAlD
Boceprevir—ABCB1—lymphoid tissue—ulcerative colitis	0.000354	0.00651	CbGeAlD
Boceprevir—ABCB1—digestive system—ulcerative colitis	0.000349	0.00643	CbGeAlD
Boceprevir—CTSL—Betamethasone—Budesonide—ulcerative colitis	0.000298	0.0568	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Budesonide—ulcerative colitis	0.000298	0.0568	CbGdCrCtD
Boceprevir—CTSL—Fluticasone Propionate—Methylprednisolone—ulcerative colitis	0.000284	0.0541	CbGdCrCtD
Boceprevir—CTSL—Fluticasone Propionate—Betamethasone—ulcerative colitis	0.00028	0.0533	CbGdCrCtD
Boceprevir—CTSL—Fluticasone Propionate—Dexamethasone—ulcerative colitis	0.00028	0.0533	CbGdCrCtD
Boceprevir—CTSL—Fluticasone Propionate—Triamcinolone—ulcerative colitis	0.000273	0.052	CbGdCrCtD
Boceprevir—ABCB1—liver—ulcerative colitis	0.00026	0.00479	CbGeAlD
Boceprevir—CTSL—Dexamethasone—Hydrocortisone—ulcerative colitis	0.000153	0.0291	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Hydrocortisone—ulcerative colitis	0.000153	0.0291	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Methylprednisolone—ulcerative colitis	0.000144	0.0274	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Methylprednisolone—ulcerative colitis	0.000144	0.0274	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Betamethasone—ulcerative colitis	0.000142	0.027	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Dexamethasone—ulcerative colitis	0.000142	0.027	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Triamcinolone—ulcerative colitis	0.000139	0.0264	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Triamcinolone—ulcerative colitis	0.000139	0.0264	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Prednisone—ulcerative colitis	0.000131	0.025	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Prednisone—ulcerative colitis	0.000131	0.025	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Prednisolone—ulcerative colitis	0.000128	0.0244	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Prednisolone—ulcerative colitis	0.000128	0.0244	CbGdCrCtD
Boceprevir—CTSK—Immune System—CCR6—ulcerative colitis	0.000124	0.000819	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IRF8—ulcerative colitis	0.000124	0.000819	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL17A—ulcerative colitis	0.000123	0.000812	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CXCR1—ulcerative colitis	0.000122	0.000808	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—NOD2—ulcerative colitis	0.000122	0.000807	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—TLR4—ulcerative colitis	0.000122	0.000806	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—TLR4—ulcerative colitis	0.000122	0.000806	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD79A—ulcerative colitis	0.000121	0.000804	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CD14—ulcerative colitis	0.000121	0.000803	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—ADCY5—ulcerative colitis	0.00012	0.000796	CbGpPWpGaD
Boceprevir—CTSK—Toll-Like Receptors Cascades—IL6—ulcerative colitis	0.000119	0.000786	CbGpPWpGaD
Boceprevir—CTSK—Immune System—FCGR2A—ulcerative colitis	0.000118	0.000781	CbGpPWpGaD
Boceprevir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000117	0.000777	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—HLA-DRB1—ulcerative colitis	0.000117	0.000773	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—HLA-DRB1—ulcerative colitis	0.000117	0.000773	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CALM3—ulcerative colitis	0.000117	0.000772	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CALM3—ulcerative colitis	0.000117	0.000772	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—MMP9—ulcerative colitis	0.000116	0.000766	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—TGFB1—ulcerative colitis	0.000115	0.000762	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—TGFB1—ulcerative colitis	0.000115	0.000762	CbGpPWpGaD
Boceprevir—CTSV—Immune System—RIPK2—ulcerative colitis	0.000115	0.00076	CbGpPWpGaD
Boceprevir—CTSL—Immune System—RIPK2—ulcerative colitis	0.000115	0.00076	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL12B—ulcerative colitis	0.000114	0.000755	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CTLA4—ulcerative colitis	0.000113	0.000749	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CTLA4—ulcerative colitis	0.000113	0.000749	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PTPN2—ulcerative colitis	0.000113	0.000749	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—VCAM1—ulcerative colitis	0.000112	0.000744	CbGpPWpGaD
Boceprevir—CTSS—Immune System—ITGAL—ulcerative colitis	0.000112	0.000743	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—ICAM1—ulcerative colitis	0.000112	0.000742	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—ICAM1—ulcerative colitis	0.000112	0.000742	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—HLA-DQA1—ulcerative colitis	0.000112	0.000742	CbGpPWpGaD
Boceprevir—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000109	0.000722	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD79A—ulcerative colitis	0.000108	0.000715	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD79A—ulcerative colitis	0.000108	0.000715	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—CTLA4—ulcerative colitis	0.000107	0.00071	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCL20—ulcerative colitis	0.000107	0.000709	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—TGFB1—ulcerative colitis	0.000107	0.000708	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IRF5—ulcerative colitis	0.000107	0.000706	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CRP—ulcerative colitis	0.000105	0.000697	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—MMP1—ulcerative colitis	0.000104	0.000691	CbGpPWpGaD
Boceprevir—CTSL—Immune System—NOD2—ulcerative colitis	0.000104	0.000689	CbGpPWpGaD
Boceprevir—CTSV—Immune System—NOD2—ulcerative colitis	0.000104	0.000689	CbGpPWpGaD
Boceprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000104	0.000688	CbGpPWpGaD
Boceprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000104	0.000686	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD14—ulcerative colitis	0.000104	0.000685	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD14—ulcerative colitis	0.000104	0.000685	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IRF8—ulcerative colitis	0.000102	0.000674	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CCR6—ulcerative colitis	0.000102	0.000674	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—TLR4—ulcerative colitis	0.000101	0.000668	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—GNA12—ulcerative colitis	0.000101	0.000667	CbGpPWpGaD
Boceprevir—CTSL—Immune System—VCAM1—ulcerative colitis	9.99e-05	0.000661	CbGpPWpGaD
Boceprevir—CTSV—Immune System—VCAM1—ulcerative colitis	9.99e-05	0.000661	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HLA-DQA1—ulcerative colitis	9.96e-05	0.00066	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HLA-DQA1—ulcerative colitis	9.96e-05	0.00066	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CDH1—ulcerative colitis	9.92e-05	0.000656	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CDH1—ulcerative colitis	9.92e-05	0.000656	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—ADCY5—ulcerative colitis	9.91e-05	0.000656	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—IL6—ulcerative colitis	9.78e-05	0.000647	CbGpPWpGaD
Boceprevir—CTSS—Immune System—FCGR2A—ulcerative colitis	9.72e-05	0.000643	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—HLA-DRB1—ulcerative colitis	9.68e-05	0.000641	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CALM3—ulcerative colitis	9.66e-05	0.000639	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CXCR2—ulcerative colitis	9.55e-05	0.000632	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—TGFB1—ulcerative colitis	9.54e-05	0.000631	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—MMP9—ulcerative colitis	9.53e-05	0.000631	CbGpPWpGaD
Boceprevir—CTSK—Immune System—RIPK2—ulcerative colitis	9.51e-05	0.00063	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—HLA-DQA1—ulcerative colitis	9.44e-05	0.000625	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CTLA4—ulcerative colitis	9.38e-05	0.000621	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PTPN2—ulcerative colitis	9.32e-05	0.000617	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—ICAM1—ulcerative colitis	9.29e-05	0.000615	CbGpPWpGaD
Boceprevir—Loss of consciousness—Methylprednisolone—ulcerative colitis	9.2e-05	0.000473	CcSEcCtD
Boceprevir—Asthenia—Mesalazine—ulcerative colitis	9.17e-05	0.000472	CcSEcCtD
Boceprevir—Shock—Prednisolone—ulcerative colitis	9.16e-05	0.000471	CcSEcCtD
Boceprevir—Cough—Triamcinolone—ulcerative colitis	9.15e-05	0.000471	CcSEcCtD
Boceprevir—Tachycardia—Prednisolone—ulcerative colitis	9.08e-05	0.000467	CcSEcCtD
Boceprevir—Hypertension—Triamcinolone—ulcerative colitis	9.06e-05	0.000466	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—JAK2—ulcerative colitis	9.05e-05	0.000599	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—JAK2—ulcerative colitis	9.05e-05	0.000599	CbGpPWpGaD
Boceprevir—Pruritus—Mesalazine—ulcerative colitis	9.04e-05	0.000465	CcSEcCtD
Boceprevir—Hypertension—Methylprednisolone—ulcerative colitis	9.04e-05	0.000465	CcSEcCtD
Boceprevir—Infection—Hydrocortisone—ulcerative colitis	9.03e-05	0.000464	CcSEcCtD
Boceprevir—Hyperhidrosis—Prednisolone—ulcerative colitis	9e-05	0.000463	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CCR6—ulcerative colitis	8.98e-05	0.000594	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD79A—ulcerative colitis	8.95e-05	0.000592	CbGpPWpGaD
Boceprevir—Shock—Hydrocortisone—ulcerative colitis	8.94e-05	0.00046	CcSEcCtD
Boceprevir—Myalgia—Triamcinolone—ulcerative colitis	8.93e-05	0.000459	CcSEcCtD
Boceprevir—Vomiting—Azathioprine—ulcerative colitis	8.92e-05	0.000459	CcSEcCtD
Boceprevir—Nervous system disorder—Hydrocortisone—ulcerative colitis	8.92e-05	0.000458	CcSEcCtD
Boceprevir—Myalgia—Methylprednisolone—ulcerative colitis	8.91e-05	0.000458	CcSEcCtD
Boceprevir—Arthralgia—Methylprednisolone—ulcerative colitis	8.91e-05	0.000458	CcSEcCtD
Boceprevir—Eye disorder—Prednisone—ulcerative colitis	8.9e-05	0.000457	CcSEcCtD
Boceprevir—Anxiety—Methylprednisolone—ulcerative colitis	8.88e-05	0.000457	CcSEcCtD
Boceprevir—Tachycardia—Hydrocortisone—ulcerative colitis	8.87e-05	0.000456	CcSEcCtD
Boceprevir—Rash—Azathioprine—ulcerative colitis	8.85e-05	0.000455	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	8.85e-05	0.000455	CcSEcCtD
Boceprevir—Dermatitis—Azathioprine—ulcerative colitis	8.84e-05	0.000455	CcSEcCtD
Boceprevir—Flushing—Prednisone—ulcerative colitis	8.84e-05	0.000454	CcSEcCtD
Boceprevir—Skin disorder—Hydrocortisone—ulcerative colitis	8.83e-05	0.000454	CcSEcCtD
Boceprevir—Ill-defined disorder—Dexamethasone—ulcerative colitis	8.83e-05	0.000454	CcSEcCtD
Boceprevir—Ill-defined disorder—Betamethasone—ulcerative colitis	8.83e-05	0.000454	CcSEcCtD
Boceprevir—Discomfort—Triamcinolone—ulcerative colitis	8.82e-05	0.000454	CcSEcCtD
Boceprevir—Discomfort—Methylprednisolone—ulcerative colitis	8.8e-05	0.000453	CcSEcCtD
Boceprevir—Headache—Azathioprine—ulcerative colitis	8.79e-05	0.000452	CcSEcCtD
Boceprevir—Hyperhidrosis—Hydrocortisone—ulcerative colitis	8.79e-05	0.000452	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—RELA—ulcerative colitis	8.77e-05	0.00058	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—RELA—ulcerative colitis	8.77e-05	0.00058	CbGpPWpGaD
Boceprevir—Diarrhoea—Mesalazine—ulcerative colitis	8.75e-05	0.00045	CcSEcCtD
Boceprevir—Dry mouth—Triamcinolone—ulcerative colitis	8.73e-05	0.000449	CcSEcCtD
Boceprevir—CYP3A5—Biological oxidations—PTGS1—ulcerative colitis	8.72e-05	0.000578	CbGpPWpGaD
Boceprevir—Angioedema—Dexamethasone—ulcerative colitis	8.7e-05	0.000447	CcSEcCtD
Boceprevir—Angioedema—Betamethasone—ulcerative colitis	8.7e-05	0.000447	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—CRP—ulcerative colitis	8.67e-05	0.000574	CbGpPWpGaD
Boceprevir—Angiopathy—Prednisone—ulcerative colitis	8.64e-05	0.000444	CcSEcCtD
Boceprevir—CTSK—Immune System—NOD2—ulcerative colitis	8.63e-05	0.000571	CbGpPWpGaD
Boceprevir—Confusional state—Methylprednisolone—ulcerative colitis	8.61e-05	0.000443	CcSEcCtD
Boceprevir—Immune system disorder—Prednisone—ulcerative colitis	8.6e-05	0.000442	CcSEcCtD
Boceprevir—Malaise—Dexamethasone—ulcerative colitis	8.58e-05	0.000441	CcSEcCtD
Boceprevir—Malaise—Betamethasone—ulcerative colitis	8.58e-05	0.000441	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—CD4—ulcerative colitis	8.58e-05	0.000568	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CD4—ulcerative colitis	8.58e-05	0.000568	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD14—ulcerative colitis	8.58e-05	0.000568	CbGpPWpGaD
Boceprevir—Vertigo—Betamethasone—ulcerative colitis	8.55e-05	0.00044	CcSEcCtD
Boceprevir—Vertigo—Dexamethasone—ulcerative colitis	8.55e-05	0.00044	CcSEcCtD
Boceprevir—Syncope—Dexamethasone—ulcerative colitis	8.53e-05	0.000439	CcSEcCtD
Boceprevir—Syncope—Betamethasone—ulcerative colitis	8.53e-05	0.000439	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—MAML2—ulcerative colitis	8.51e-05	0.000563	CbGpPWpGaD
Boceprevir—Arrhythmia—Prednisone—ulcerative colitis	8.5e-05	0.000437	CcSEcCtD
Boceprevir—Infection—Triamcinolone—ulcerative colitis	8.5e-05	0.000437	CcSEcCtD
Boceprevir—Hypotension—Hydrocortisone—ulcerative colitis	8.49e-05	0.000437	CcSEcCtD
Boceprevir—Infection—Methylprednisolone—ulcerative colitis	8.49e-05	0.000436	CcSEcCtD
Boceprevir—CTSL—Immune System—ADCY5—ulcerative colitis	8.46e-05	0.00056	CbGpPWpGaD
Boceprevir—CTSV—Immune System—ADCY5—ulcerative colitis	8.46e-05	0.00056	CbGpPWpGaD
Boceprevir—Dizziness—Mesalazine—ulcerative colitis	8.45e-05	0.000435	CcSEcCtD
Boceprevir—Shock—Triamcinolone—ulcerative colitis	8.42e-05	0.000433	CcSEcCtD
Boceprevir—Insomnia—Prednisolone—ulcerative colitis	8.42e-05	0.000433	CcSEcCtD
Boceprevir—CTSL—Adaptive Immune System—RELA—ulcerative colitis	8.42e-05	0.000557	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—RELA—ulcerative colitis	8.42e-05	0.000557	CbGpPWpGaD
Boceprevir—Alopecia—Prednisone—ulcerative colitis	8.41e-05	0.000433	CcSEcCtD
Boceprevir—Shock—Methylprednisolone—ulcerative colitis	8.4e-05	0.000432	CcSEcCtD
Boceprevir—Nervous system disorder—Methylprednisolone—ulcerative colitis	8.38e-05	0.000431	CcSEcCtD
Boceprevir—Loss of consciousness—Dexamethasone—ulcerative colitis	8.36e-05	0.00043	CcSEcCtD
Boceprevir—Loss of consciousness—Betamethasone—ulcerative colitis	8.36e-05	0.00043	CcSEcCtD
Boceprevir—Paraesthesia—Prednisolone—ulcerative colitis	8.36e-05	0.00043	CcSEcCtD
Boceprevir—Tachycardia—Triamcinolone—ulcerative colitis	8.35e-05	0.00043	CcSEcCtD
Boceprevir—Mental disorder—Prednisone—ulcerative colitis	8.34e-05	0.000429	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—IL10—ulcerative colitis	8.34e-05	0.000552	CbGpPWpGaD
Boceprevir—Nausea—Azathioprine—ulcerative colitis	8.34e-05	0.000429	CcSEcCtD
Boceprevir—Tachycardia—Methylprednisolone—ulcerative colitis	8.34e-05	0.000429	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—TLR4—ulcerative colitis	8.31e-05	0.00055	CbGpPWpGaD
Boceprevir—Skin disorder—Methylprednisolone—ulcerative colitis	8.3e-05	0.000427	CcSEcCtD
Boceprevir—Erythema—Prednisone—ulcerative colitis	8.29e-05	0.000426	CcSEcCtD
Boceprevir—Malnutrition—Prednisone—ulcerative colitis	8.29e-05	0.000426	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	8.28e-05	0.000426	CcSEcCtD
Boceprevir—CTSK—Immune System—VCAM1—ulcerative colitis	8.28e-05	0.000548	CbGpPWpGaD
Boceprevir—Hyperhidrosis—Triamcinolone—ulcerative colitis	8.28e-05	0.000425	CcSEcCtD
Boceprevir—Hyperhidrosis—Methylprednisolone—ulcerative colitis	8.26e-05	0.000425	CcSEcCtD
Boceprevir—CTSK—Immune System—HLA-DQA1—ulcerative colitis	8.26e-05	0.000546	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD4—ulcerative colitis	8.24e-05	0.000545	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD4—ulcerative colitis	8.24e-05	0.000545	CbGpPWpGaD
Boceprevir—Insomnia—Hydrocortisone—ulcerative colitis	8.22e-05	0.000423	CcSEcCtD
Boceprevir—Hypertension—Betamethasone—ulcerative colitis	8.22e-05	0.000422	CcSEcCtD
Boceprevir—Hypertension—Dexamethasone—ulcerative colitis	8.22e-05	0.000422	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—CDH1—ulcerative colitis	8.22e-05	0.000544	CbGpPWpGaD
Boceprevir—Paraesthesia—Hydrocortisone—ulcerative colitis	8.16e-05	0.00042	CcSEcCtD
Boceprevir—Vomiting—Mesalazine—ulcerative colitis	8.13e-05	0.000418	CcSEcCtD
Boceprevir—Myalgia—Betamethasone—ulcerative colitis	8.1e-05	0.000417	CcSEcCtD
Boceprevir—Myalgia—Dexamethasone—ulcerative colitis	8.1e-05	0.000417	CcSEcCtD
Boceprevir—Anxiety—Dexamethasone—ulcerative colitis	8.07e-05	0.000415	CcSEcCtD
Boceprevir—Anxiety—Betamethasone—ulcerative colitis	8.07e-05	0.000415	CcSEcCtD
Boceprevir—Rash—Mesalazine—ulcerative colitis	8.06e-05	0.000414	CcSEcCtD
Boceprevir—Dermatitis—Mesalazine—ulcerative colitis	8.05e-05	0.000414	CcSEcCtD
Boceprevir—Headache—Mesalazine—ulcerative colitis	8.01e-05	0.000412	CcSEcCtD
Boceprevir—Discomfort—Dexamethasone—ulcerative colitis	8e-05	0.000412	CcSEcCtD
Boceprevir—Discomfort—Betamethasone—ulcerative colitis	8e-05	0.000412	CcSEcCtD
Boceprevir—Dyspepsia—Hydrocortisone—ulcerative colitis	8e-05	0.000411	CcSEcCtD
Boceprevir—Hypotension—Methylprednisolone—ulcerative colitis	7.98e-05	0.00041	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—HLA-DRB1—ulcerative colitis	7.97e-05	0.000528	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	7.97e-05	0.000527	CbGpPWpGaD
Boceprevir—Pain—Prednisolone—ulcerative colitis	7.96e-05	0.000409	CcSEcCtD
Boceprevir—CTSS—Immune System—CALM3—ulcerative colitis	7.95e-05	0.000527	CbGpPWpGaD
Boceprevir—Decreased appetite—Hydrocortisone—ulcerative colitis	7.9e-05	0.000406	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—PTGER4—ulcerative colitis	7.9e-05	0.000523	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—TGFB1—ulcerative colitis	7.86e-05	0.00052	CbGpPWpGaD
Boceprevir—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	7.85e-05	0.000404	CcSEcCtD
Boceprevir—Fatigue—Hydrocortisone—ulcerative colitis	7.84e-05	0.000403	CcSEcCtD
Boceprevir—CTSS—Immune System—RIPK2—ulcerative colitis	7.84e-05	0.000519	CbGpPWpGaD
Boceprevir—Vision blurred—Prednisone—ulcerative colitis	7.81e-05	0.000402	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	7.8e-05	0.000401	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	7.78e-05	0.0004	CcSEcCtD
Boceprevir—Pain—Hydrocortisone—ulcerative colitis	7.77e-05	0.0004	CcSEcCtD
Boceprevir—Insomnia—Triamcinolone—ulcerative colitis	7.74e-05	0.000398	CcSEcCtD
Boceprevir—Insomnia—Methylprednisolone—ulcerative colitis	7.72e-05	0.000397	CcSEcCtD
Boceprevir—CTSS—Immune System—CTLA4—ulcerative colitis	7.72e-05	0.000511	CbGpPWpGaD
Boceprevir—Infection—Betamethasone—ulcerative colitis	7.72e-05	0.000397	CcSEcCtD
Boceprevir—Infection—Dexamethasone—ulcerative colitis	7.72e-05	0.000397	CcSEcCtD
Boceprevir—Ill-defined disorder—Prednisone—ulcerative colitis	7.69e-05	0.000395	CcSEcCtD
Boceprevir—Paraesthesia—Triamcinolone—ulcerative colitis	7.69e-05	0.000395	CcSEcCtD
Boceprevir—Feeling abnormal—Prednisolone—ulcerative colitis	7.67e-05	0.000394	CcSEcCtD
Boceprevir—Paraesthesia—Methylprednisolone—ulcerative colitis	7.67e-05	0.000394	CcSEcCtD
Boceprevir—Anaemia—Prednisone—ulcerative colitis	7.66e-05	0.000394	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—ICAM1—ulcerative colitis	7.65e-05	0.000506	CbGpPWpGaD
Boceprevir—Shock—Betamethasone—ulcerative colitis	7.64e-05	0.000393	CcSEcCtD
Boceprevir—Shock—Dexamethasone—ulcerative colitis	7.64e-05	0.000393	CcSEcCtD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	7.64e-05	0.000505	CbGpPWpGaD
Boceprevir—Dyspnoea—Triamcinolone—ulcerative colitis	7.63e-05	0.000392	CcSEcCtD
Boceprevir—Nervous system disorder—Betamethasone—ulcerative colitis	7.62e-05	0.000392	CcSEcCtD
Boceprevir—Nervous system disorder—Dexamethasone—ulcerative colitis	7.62e-05	0.000392	CcSEcCtD
Boceprevir—Agitation—Prednisone—ulcerative colitis	7.62e-05	0.000392	CcSEcCtD
Boceprevir—Thrombocytopenia—Betamethasone—ulcerative colitis	7.6e-05	0.000391	CcSEcCtD
Boceprevir—Thrombocytopenia—Dexamethasone—ulcerative colitis	7.6e-05	0.000391	CcSEcCtD
Boceprevir—Nausea—Mesalazine—ulcerative colitis	7.59e-05	0.00039	CcSEcCtD
Boceprevir—Tachycardia—Betamethasone—ulcerative colitis	7.58e-05	0.00039	CcSEcCtD
Boceprevir—Tachycardia—Dexamethasone—ulcerative colitis	7.58e-05	0.00039	CcSEcCtD
Boceprevir—Angioedema—Prednisone—ulcerative colitis	7.57e-05	0.000389	CcSEcCtD
Boceprevir—Dyspepsia—Triamcinolone—ulcerative colitis	7.53e-05	0.000387	CcSEcCtD
Boceprevir—Dyspepsia—Methylprednisolone—ulcerative colitis	7.52e-05	0.000387	CcSEcCtD
Boceprevir—Hyperhidrosis—Betamethasone—ulcerative colitis	7.51e-05	0.000386	CcSEcCtD
Boceprevir—Hyperhidrosis—Dexamethasone—ulcerative colitis	7.51e-05	0.000386	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—JAK2—ulcerative colitis	7.5e-05	0.000497	CbGpPWpGaD
Boceprevir—Feeling abnormal—Hydrocortisone—ulcerative colitis	7.49e-05	0.000385	CcSEcCtD
Boceprevir—Malaise—Prednisone—ulcerative colitis	7.47e-05	0.000384	CcSEcCtD
Boceprevir—Vertigo—Prednisone—ulcerative colitis	7.45e-05	0.000383	CcSEcCtD
Boceprevir—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	7.43e-05	0.000382	CcSEcCtD
Boceprevir—Syncope—Prednisone—ulcerative colitis	7.43e-05	0.000382	CcSEcCtD
Boceprevir—CTSL—Immune System—CRP—ulcerative colitis	7.4e-05	0.00049	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CRP—ulcerative colitis	7.4e-05	0.00049	CbGpPWpGaD
Boceprevir—Urticaria—Prednisolone—ulcerative colitis	7.39e-05	0.00038	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—NFKB1—ulcerative colitis	7.39e-05	0.000489	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—NFKB1—ulcerative colitis	7.39e-05	0.000489	CbGpPWpGaD
Boceprevir—Fatigue—Triamcinolone—ulcerative colitis	7.38e-05	0.000379	CcSEcCtD
Boceprevir—CTSS—Immune System—CD79A—ulcerative colitis	7.37e-05	0.000488	CbGpPWpGaD
Boceprevir—Fatigue—Methylprednisolone—ulcerative colitis	7.36e-05	0.000379	CcSEcCtD
Boceprevir—Pain—Triamcinolone—ulcerative colitis	7.32e-05	0.000376	CcSEcCtD
Boceprevir—Loss of consciousness—Prednisone—ulcerative colitis	7.28e-05	0.000375	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—RELA—ulcerative colitis	7.26e-05	0.000481	CbGpPWpGaD
Boceprevir—Hypotension—Betamethasone—ulcerative colitis	7.26e-05	0.000373	CcSEcCtD
Boceprevir—Hypotension—Dexamethasone—ulcerative colitis	7.26e-05	0.000373	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—GHRL—ulcerative colitis	7.23e-05	0.000479	CbGpPWpGaD
Boceprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	7.23e-05	0.000478	CbGpPWpGaD
Boceprevir—Urticaria—Hydrocortisone—ulcerative colitis	7.22e-05	0.000371	CcSEcCtD
Boceprevir—Abdominal pain—Hydrocortisone—ulcerative colitis	7.19e-05	0.00037	CcSEcCtD
Boceprevir—Body temperature increased—Hydrocortisone—ulcerative colitis	7.19e-05	0.00037	CcSEcCtD
Boceprevir—Hypertension—Prednisone—ulcerative colitis	7.16e-05	0.000368	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—CD4—ulcerative colitis	7.11e-05	0.000471	CbGpPWpGaD
Boceprevir—CTSS—Immune System—NOD2—ulcerative colitis	7.1e-05	0.00047	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—NFKB1—ulcerative colitis	7.1e-05	0.00047	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—NFKB1—ulcerative colitis	7.1e-05	0.00047	CbGpPWpGaD
Boceprevir—CTSL—Immune System—TLR4—ulcerative colitis	7.09e-05	0.00047	CbGpPWpGaD
Boceprevir—CTSV—Immune System—TLR4—ulcerative colitis	7.09e-05	0.00047	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HLA-DRB1—ulcerative colitis	7.09e-05	0.000469	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HLA-DRB1—ulcerative colitis	7.09e-05	0.000469	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	7.08e-05	0.000364	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	7.08e-05	0.000364	CcSEcCtD
Boceprevir—CTSS—Immune System—CD14—ulcerative colitis	7.06e-05	0.000468	CbGpPWpGaD
Boceprevir—Arthralgia—Prednisone—ulcerative colitis	7.06e-05	0.000363	CcSEcCtD
Boceprevir—Myalgia—Prednisone—ulcerative colitis	7.06e-05	0.000363	CcSEcCtD
Boceprevir—Feeling abnormal—Triamcinolone—ulcerative colitis	7.05e-05	0.000363	CcSEcCtD
Boceprevir—Feeling abnormal—Methylprednisolone—ulcerative colitis	7.04e-05	0.000362	CcSEcCtD
Boceprevir—Anxiety—Prednisone—ulcerative colitis	7.03e-05	0.000362	CcSEcCtD
Boceprevir—Insomnia—Betamethasone—ulcerative colitis	7.02e-05	0.000361	CcSEcCtD
Boceprevir—Insomnia—Dexamethasone—ulcerative colitis	7.02e-05	0.000361	CcSEcCtD
Boceprevir—CTSK—Immune System—ADCY5—ulcerative colitis	7.01e-05	0.000464	CbGpPWpGaD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	7.01e-05	0.00036	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CALM3—ulcerative colitis	7.01e-05	0.000464	CbGpPWpGaD
Boceprevir—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	6.98e-05	0.000359	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—RELA—ulcerative colitis	6.98e-05	0.000462	CbGpPWpGaD
Boceprevir—Paraesthesia—Betamethasone—ulcerative colitis	6.97e-05	0.000359	CcSEcCtD
Boceprevir—Paraesthesia—Dexamethasone—ulcerative colitis	6.97e-05	0.000359	CcSEcCtD
Boceprevir—Discomfort—Prednisone—ulcerative colitis	6.97e-05	0.000358	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—RIPK2—ulcerative colitis	6.9e-05	0.000457	CbGpPWpGaD
Boceprevir—Hypersensitivity—Prednisolone—ulcerative colitis	6.86e-05	0.000353	CcSEcCtD
Boceprevir—Dyspepsia—Betamethasone—ulcerative colitis	6.84e-05	0.000352	CcSEcCtD
Boceprevir—Dyspepsia—Dexamethasone—ulcerative colitis	6.84e-05	0.000352	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—CD4—ulcerative colitis	6.83e-05	0.000452	CbGpPWpGaD
Boceprevir—CTSS—Immune System—VCAM1—ulcerative colitis	6.82e-05	0.000451	CbGpPWpGaD
Boceprevir—CTSL—Immune System—ICAM1—ulcerative colitis	6.8e-05	0.00045	CbGpPWpGaD
Boceprevir—CTSV—Immune System—ICAM1—ulcerative colitis	6.8e-05	0.00045	CbGpPWpGaD
Boceprevir—Urticaria—Triamcinolone—ulcerative colitis	6.8e-05	0.00035	CcSEcCtD
Boceprevir—CTSS—Immune System—HLA-DQA1—ulcerative colitis	6.8e-05	0.00045	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	6.79e-05	0.00045	CbGpPWpGaD
Boceprevir—Urticaria—Methylprednisolone—ulcerative colitis	6.79e-05	0.000349	CcSEcCtD
Boceprevir—Body temperature increased—Triamcinolone—ulcerative colitis	6.77e-05	0.000348	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—CDH1—ulcerative colitis	6.77e-05	0.000448	CbGpPWpGaD
Boceprevir—Abdominal pain—Methylprednisolone—ulcerative colitis	6.75e-05	0.000347	CcSEcCtD
Boceprevir—Decreased appetite—Betamethasone—ulcerative colitis	6.75e-05	0.000347	CcSEcCtD
Boceprevir—Decreased appetite—Dexamethasone—ulcerative colitis	6.75e-05	0.000347	CcSEcCtD
Boceprevir—Infection—Prednisone—ulcerative colitis	6.72e-05	0.000346	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—HLA-DRB1—ulcerative colitis	6.71e-05	0.000444	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—CXCL8—ulcerative colitis	6.71e-05	0.000444	CbGpPWpGaD
Boceprevir—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	6.71e-05	0.000345	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Betamethasone—ulcerative colitis	6.71e-05	0.000345	CcSEcCtD
Boceprevir—Hypersensitivity—Hydrocortisone—ulcerative colitis	6.7e-05	0.000344	CcSEcCtD
Boceprevir—Fatigue—Betamethasone—ulcerative colitis	6.7e-05	0.000344	CcSEcCtD
Boceprevir—Fatigue—Dexamethasone—ulcerative colitis	6.7e-05	0.000344	CcSEcCtD
Boceprevir—Shock—Prednisone—ulcerative colitis	6.65e-05	0.000342	CcSEcCtD
Boceprevir—Pain—Dexamethasone—ulcerative colitis	6.64e-05	0.000342	CcSEcCtD
Boceprevir—Pain—Betamethasone—ulcerative colitis	6.64e-05	0.000342	CcSEcCtD
Boceprevir—Nervous system disorder—Prednisone—ulcerative colitis	6.63e-05	0.000341	CcSEcCtD
Boceprevir—Tachycardia—Prednisone—ulcerative colitis	6.6e-05	0.000339	CcSEcCtD
Boceprevir—Skin disorder—Prednisone—ulcerative colitis	6.57e-05	0.000338	CcSEcCtD
Boceprevir—Hyperhidrosis—Prednisone—ulcerative colitis	6.54e-05	0.000336	CcSEcCtD
Boceprevir—Asthenia—Hydrocortisone—ulcerative colitis	6.52e-05	0.000335	CcSEcCtD
Boceprevir—Pruritus—Hydrocortisone—ulcerative colitis	6.43e-05	0.000331	CcSEcCtD
Boceprevir—Feeling abnormal—Dexamethasone—ulcerative colitis	6.4e-05	0.000329	CcSEcCtD
Boceprevir—Feeling abnormal—Betamethasone—ulcerative colitis	6.4e-05	0.000329	CcSEcCtD
Boceprevir—Gastrointestinal pain—Betamethasone—ulcerative colitis	6.35e-05	0.000327	CcSEcCtD
Boceprevir—Gastrointestinal pain—Dexamethasone—ulcerative colitis	6.35e-05	0.000327	CcSEcCtD
Boceprevir—Hypersensitivity—Triamcinolone—ulcerative colitis	6.31e-05	0.000324	CcSEcCtD
Boceprevir—Hypersensitivity—Methylprednisolone—ulcerative colitis	6.29e-05	0.000324	CcSEcCtD
Boceprevir—Diarrhoea—Hydrocortisone—ulcerative colitis	6.22e-05	0.00032	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—JAK2—ulcerative colitis	6.18e-05	0.000409	CbGpPWpGaD
Boceprevir—Urticaria—Dexamethasone—ulcerative colitis	6.17e-05	0.000317	CcSEcCtD
Boceprevir—Urticaria—Betamethasone—ulcerative colitis	6.17e-05	0.000317	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Prednisone—ulcerative colitis	6.16e-05	0.000317	CcSEcCtD
Boceprevir—Dizziness—Prednisolone—ulcerative colitis	6.16e-05	0.000316	CcSEcCtD
Boceprevir—Asthenia—Triamcinolone—ulcerative colitis	6.14e-05	0.000316	CcSEcCtD
Boceprevir—Body temperature increased—Dexamethasone—ulcerative colitis	6.14e-05	0.000316	CcSEcCtD
Boceprevir—Abdominal pain—Dexamethasone—ulcerative colitis	6.14e-05	0.000316	CcSEcCtD
Boceprevir—Abdominal pain—Betamethasone—ulcerative colitis	6.14e-05	0.000316	CcSEcCtD
Boceprevir—Body temperature increased—Betamethasone—ulcerative colitis	6.14e-05	0.000316	CcSEcCtD
Boceprevir—CTSK—Immune System—CRP—ulcerative colitis	6.13e-05	0.000406	CbGpPWpGaD
Boceprevir—Asthenia—Methylprednisolone—ulcerative colitis	6.13e-05	0.000315	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—NFKB1—ulcerative colitis	6.13e-05	0.000406	CbGpPWpGaD
Boceprevir—Insomnia—Prednisone—ulcerative colitis	6.12e-05	0.000315	CcSEcCtD
Boceprevir—Paraesthesia—Prednisone—ulcerative colitis	6.07e-05	0.000312	CcSEcCtD
Boceprevir—Pruritus—Triamcinolone—ulcerative colitis	6.06e-05	0.000311	CcSEcCtD
Boceprevir—Pruritus—Methylprednisolone—ulcerative colitis	6.04e-05	0.000311	CcSEcCtD
Boceprevir—CTSL—Immune System—CDH1—ulcerative colitis	6.01e-05	0.000398	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CDH1—ulcerative colitis	6.01e-05	0.000398	CbGpPWpGaD
Boceprevir—Dizziness—Hydrocortisone—ulcerative colitis	6.01e-05	0.000309	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—ADRB2—ulcerative colitis	5.99e-05	0.000396	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—RELA—ulcerative colitis	5.98e-05	0.000396	CbGpPWpGaD
Boceprevir—Dyspepsia—Prednisone—ulcerative colitis	5.95e-05	0.000306	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—NFKB1—ulcerative colitis	5.88e-05	0.000389	CbGpPWpGaD
Boceprevir—Decreased appetite—Prednisone—ulcerative colitis	5.88e-05	0.000302	CcSEcCtD
Boceprevir—CTSK—Immune System—TLR4—ulcerative colitis	5.88e-05	0.000389	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HLA-DRB1—ulcerative colitis	5.87e-05	0.000389	CbGpPWpGaD
Boceprevir—Rash—Prednisolone—ulcerative colitis	5.87e-05	0.000302	CcSEcCtD
Boceprevir—Dermatitis—Prednisolone—ulcerative colitis	5.86e-05	0.000301	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—CD4—ulcerative colitis	5.86e-05	0.000388	CbGpPWpGaD
Boceprevir—Diarrhoea—Methylprednisolone—ulcerative colitis	5.84e-05	0.0003	CcSEcCtD
Boceprevir—Fatigue—Prednisone—ulcerative colitis	5.83e-05	0.0003	CcSEcCtD
Boceprevir—Headache—Prednisolone—ulcerative colitis	5.83e-05	0.0003	CcSEcCtD
Boceprevir—Constipation—Prednisone—ulcerative colitis	5.78e-05	0.000297	CcSEcCtD
Boceprevir—Vomiting—Hydrocortisone—ulcerative colitis	5.78e-05	0.000297	CcSEcCtD
Boceprevir—CTSS—Immune System—ADCY5—ulcerative colitis	5.77e-05	0.000382	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—RELA—ulcerative colitis	5.74e-05	0.00038	CbGpPWpGaD
Boceprevir—Rash—Hydrocortisone—ulcerative colitis	5.73e-05	0.000295	CcSEcCtD
Boceprevir—Dermatitis—Hydrocortisone—ulcerative colitis	5.73e-05	0.000294	CcSEcCtD
Boceprevir—Headache—Hydrocortisone—ulcerative colitis	5.7e-05	0.000293	CcSEcCtD
Boceprevir—Dizziness—Triamcinolone—ulcerative colitis	5.66e-05	0.000291	CcSEcCtD
Boceprevir—Dizziness—Methylprednisolone—ulcerative colitis	5.65e-05	0.00029	CcSEcCtD
Boceprevir—CTSK—Immune System—ICAM1—ulcerative colitis	5.64e-05	0.000373	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD4—ulcerative colitis	5.62e-05	0.000372	CbGpPWpGaD
Boceprevir—Feeling abnormal—Prednisone—ulcerative colitis	5.57e-05	0.000287	CcSEcCtD
Boceprevir—Asthenia—Betamethasone—ulcerative colitis	5.57e-05	0.000287	CcSEcCtD
Boceprevir—Asthenia—Dexamethasone—ulcerative colitis	5.57e-05	0.000287	CcSEcCtD
Boceprevir—Gastrointestinal pain—Prednisone—ulcerative colitis	5.53e-05	0.000284	CcSEcCtD
Boceprevir—Nausea—Prednisolone—ulcerative colitis	5.53e-05	0.000284	CcSEcCtD
Boceprevir—Pruritus—Betamethasone—ulcerative colitis	5.5e-05	0.000283	CcSEcCtD
Boceprevir—Pruritus—Dexamethasone—ulcerative colitis	5.5e-05	0.000283	CcSEcCtD
Boceprevir—Vomiting—Triamcinolone—ulcerative colitis	5.44e-05	0.00028	CcSEcCtD
Boceprevir—Vomiting—Methylprednisolone—ulcerative colitis	5.43e-05	0.000279	CcSEcCtD
Boceprevir—Nausea—Hydrocortisone—ulcerative colitis	5.4e-05	0.000278	CcSEcCtD
Boceprevir—Rash—Triamcinolone—ulcerative colitis	5.4e-05	0.000278	CcSEcCtD
Boceprevir—Dermatitis—Triamcinolone—ulcerative colitis	5.39e-05	0.000277	CcSEcCtD
Boceprevir—Rash—Methylprednisolone—ulcerative colitis	5.39e-05	0.000277	CcSEcCtD
Boceprevir—Dermatitis—Methylprednisolone—ulcerative colitis	5.38e-05	0.000277	CcSEcCtD
Boceprevir—Urticaria—Prednisone—ulcerative colitis	5.37e-05	0.000276	CcSEcCtD
Boceprevir—Headache—Triamcinolone—ulcerative colitis	5.36e-05	0.000276	CcSEcCtD
Boceprevir—Headache—Methylprednisolone—ulcerative colitis	5.35e-05	0.000275	CcSEcCtD
Boceprevir—Body temperature increased—Prednisone—ulcerative colitis	5.35e-05	0.000275	CcSEcCtD
Boceprevir—Abdominal pain—Prednisone—ulcerative colitis	5.35e-05	0.000275	CcSEcCtD
Boceprevir—Diarrhoea—Betamethasone—ulcerative colitis	5.31e-05	0.000273	CcSEcCtD
Boceprevir—Diarrhoea—Dexamethasone—ulcerative colitis	5.31e-05	0.000273	CcSEcCtD
Boceprevir—CTSV—Immune System—JAK2—ulcerative colitis	5.27e-05	0.000349	CbGpPWpGaD
Boceprevir—CTSL—Immune System—JAK2—ulcerative colitis	5.27e-05	0.000349	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IFNG—ulcerative colitis	5.18e-05	0.000343	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IFNG—ulcerative colitis	5.18e-05	0.000343	CbGpPWpGaD
Boceprevir—Dizziness—Dexamethasone—ulcerative colitis	5.14e-05	0.000264	CcSEcCtD
Boceprevir—Dizziness—Betamethasone—ulcerative colitis	5.14e-05	0.000264	CcSEcCtD
Boceprevir—CTSV—Immune System—RELA—ulcerative colitis	5.11e-05	0.000338	CbGpPWpGaD
Boceprevir—CTSL—Immune System—RELA—ulcerative colitis	5.11e-05	0.000338	CbGpPWpGaD
Boceprevir—Nausea—Triamcinolone—ulcerative colitis	5.08e-05	0.000261	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—ADCY5—ulcerative colitis	5.08e-05	0.000336	CbGpPWpGaD
Boceprevir—Nausea—Methylprednisolone—ulcerative colitis	5.07e-05	0.000261	CcSEcCtD
Boceprevir—CTSS—Immune System—CRP—ulcerative colitis	5.05e-05	0.000334	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—NFKB1—ulcerative colitis	5.04e-05	0.000334	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD4—ulcerative colitis	5e-05	0.000331	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD4—ulcerative colitis	5e-05	0.000331	CbGpPWpGaD
Boceprevir—Hypersensitivity—Prednisone—ulcerative colitis	4.98e-05	0.000256	CcSEcCtD
Boceprevir—CTSK—Immune System—CDH1—ulcerative colitis	4.98e-05	0.00033	CbGpPWpGaD
Boceprevir—Vomiting—Betamethasone—ulcerative colitis	4.94e-05	0.000254	CcSEcCtD
Boceprevir—Vomiting—Dexamethasone—ulcerative colitis	4.94e-05	0.000254	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	4.9e-05	0.000325	CbGpPWpGaD
Boceprevir—Rash—Dexamethasone—ulcerative colitis	4.9e-05	0.000252	CcSEcCtD
Boceprevir—Rash—Betamethasone—ulcerative colitis	4.9e-05	0.000252	CcSEcCtD
Boceprevir—Dermatitis—Betamethasone—ulcerative colitis	4.89e-05	0.000252	CcSEcCtD
Boceprevir—Dermatitis—Dexamethasone—ulcerative colitis	4.89e-05	0.000252	CcSEcCtD
Boceprevir—Headache—Dexamethasone—ulcerative colitis	4.87e-05	0.00025	CcSEcCtD
Boceprevir—Headache—Betamethasone—ulcerative colitis	4.87e-05	0.00025	CcSEcCtD
Boceprevir—Asthenia—Prednisone—ulcerative colitis	4.85e-05	0.00025	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—NFKB1—ulcerative colitis	4.84e-05	0.000321	CbGpPWpGaD
Boceprevir—CTSS—Immune System—TLR4—ulcerative colitis	4.84e-05	0.00032	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HLA-DRB1—ulcerative colitis	4.84e-05	0.00032	CbGpPWpGaD
Boceprevir—Pruritus—Prednisone—ulcerative colitis	4.79e-05	0.000246	CcSEcCtD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	4.7e-05	0.000311	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	4.7e-05	0.000311	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—IL6—ulcerative colitis	4.64e-05	0.000307	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—IL6—ulcerative colitis	4.64e-05	0.000307	CbGpPWpGaD
Boceprevir—CTSS—Immune System—ICAM1—ulcerative colitis	4.64e-05	0.000307	CbGpPWpGaD
Boceprevir—Diarrhoea—Prednisone—ulcerative colitis	4.63e-05	0.000238	CcSEcCtD
Boceprevir—CTSV—Immune System—IL1B—ulcerative colitis	4.62e-05	0.000306	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL1B—ulcerative colitis	4.62e-05	0.000306	CbGpPWpGaD
Boceprevir—Nausea—Betamethasone—ulcerative colitis	4.61e-05	0.000237	CcSEcCtD
Boceprevir—Nausea—Dexamethasone—ulcerative colitis	4.61e-05	0.000237	CcSEcCtD
Boceprevir—CTSV—Immune System—IL2—ulcerative colitis	4.6e-05	0.000304	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL2—ulcerative colitis	4.6e-05	0.000304	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	4.56e-05	0.000302	CbGpPWpGaD
Boceprevir—Dizziness—Prednisone—ulcerative colitis	4.47e-05	0.00023	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	4.37e-05	0.00029	CbGpPWpGaD
Boceprevir—CTSK—Immune System—JAK2—ulcerative colitis	4.37e-05	0.000289	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL2—ulcerative colitis	4.36e-05	0.000288	CbGpPWpGaD
Boceprevir—CTSV—Immune System—NFKB1—ulcerative colitis	4.31e-05	0.000285	CbGpPWpGaD
Boceprevir—CTSL—Immune System—NFKB1—ulcerative colitis	4.31e-05	0.000285	CbGpPWpGaD
Boceprevir—Vomiting—Prednisone—ulcerative colitis	4.3e-05	0.000221	CcSEcCtD
Boceprevir—CTSK—Immune System—IFNG—ulcerative colitis	4.29e-05	0.000284	CbGpPWpGaD
Boceprevir—Rash—Prednisone—ulcerative colitis	4.26e-05	0.000219	CcSEcCtD
Boceprevir—Dermatitis—Prednisone—ulcerative colitis	4.26e-05	0.000219	CcSEcCtD
Boceprevir—Headache—Prednisone—ulcerative colitis	4.24e-05	0.000218	CcSEcCtD
Boceprevir—CTSK—Immune System—RELA—ulcerative colitis	4.23e-05	0.00028	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD4—ulcerative colitis	4.14e-05	0.000274	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CDH1—ulcerative colitis	4.1e-05	0.000272	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	4.06e-05	0.000269	CbGpPWpGaD
Boceprevir—Nausea—Prednisone—ulcerative colitis	4.02e-05	0.000207	CcSEcCtD
Boceprevir—CTSV—Immune System—STAT3—ulcerative colitis	3.87e-05	0.000256	CbGpPWpGaD
Boceprevir—CTSL—Immune System—STAT3—ulcerative colitis	3.87e-05	0.000256	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—IL6—ulcerative colitis	3.85e-05	0.000255	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL1B—ulcerative colitis	3.82e-05	0.000253	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL2—ulcerative colitis	3.81e-05	0.000252	CbGpPWpGaD
Boceprevir—CTSS—Immune System—JAK2—ulcerative colitis	3.6e-05	0.000238	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CHP1—ulcerative colitis	3.58e-05	0.000237	CbGpPWpGaD
Boceprevir—CTSK—Immune System—NFKB1—ulcerative colitis	3.57e-05	0.000236	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IFNG—ulcerative colitis	3.53e-05	0.000234	CbGpPWpGaD
Boceprevir—CTSS—Immune System—RELA—ulcerative colitis	3.48e-05	0.000231	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD4—ulcerative colitis	3.41e-05	0.000226	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	3.4e-05	0.000225	CbGpPWpGaD
Boceprevir—CTSK—Immune System—STAT3—ulcerative colitis	3.21e-05	0.000212	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TNF—ulcerative colitis	3.17e-05	0.00021	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—JAK2—ulcerative colitis	3.17e-05	0.00021	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—IL6—ulcerative colitis	3.17e-05	0.00021	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL1B—ulcerative colitis	3.15e-05	0.000209	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL2—ulcerative colitis	3.14e-05	0.000208	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—DLD—ulcerative colitis	3.09e-05	0.000204	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—RELA—ulcerative colitis	3.07e-05	0.000203	CbGpPWpGaD
Boceprevir—CTSS—Immune System—NFKB1—ulcerative colitis	2.94e-05	0.000195	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.92e-05	0.000194	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CXCL8—ulcerative colitis	2.89e-05	0.000191	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL2—ulcerative colitis	2.76e-05	0.000183	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL6—ulcerative colitis	2.7e-05	0.000179	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL6—ulcerative colitis	2.7e-05	0.000179	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CHP1—ulcerative colitis	2.7e-05	0.000179	CbGpPWpGaD
Boceprevir—CTSS—Immune System—STAT3—ulcerative colitis	2.64e-05	0.000175	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MMP9—ulcerative colitis	2.62e-05	0.000173	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NFKB1—ulcerative colitis	2.59e-05	0.000171	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—DLD—ulcerative colitis	2.33e-05	0.000154	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—STAT3—ulcerative colitis	2.33e-05	0.000154	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	2.32e-05	0.000154	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL6—ulcerative colitis	2.24e-05	0.000148	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TGFB1—ulcerative colitis	2.16e-05	0.000143	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	2.01e-05	0.000133	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL6—ulcerative colitis	1.84e-05	0.000122	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—ulcerative colitis	1.77e-05	0.000117	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.68e-05	0.000111	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CHP1—ulcerative colitis	1.66e-05	0.00011	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL6—ulcerative colitis	1.62e-05	0.000108	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.57e-05	0.000104	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.57e-05	0.000104	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS1—ulcerative colitis	1.49e-05	9.88e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—DLD—ulcerative colitis	1.43e-05	9.5e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.38e-05	9.14e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CALM3—ulcerative colitis	1.34e-05	8.89e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS1—ulcerative colitis	1.13e-05	7.45e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.05e-05	6.97e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ABCB1—ulcerative colitis	1.04e-05	6.92e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CALM3—ulcerative colitis	1.01e-05	6.71e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ADCY5—ulcerative colitis	9.75e-06	6.45e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ADCY5—ulcerative colitis	7.35e-06	4.87e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPARG—ulcerative colitis	7.27e-06	4.81e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS1—ulcerative colitis	6.94e-06	4.59e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALB—ulcerative colitis	6.54e-06	4.33e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CALM3—ulcerative colitis	6.25e-06	4.13e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS2—ulcerative colitis	5.72e-06	3.79e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPARG—ulcerative colitis	5.48e-06	3.63e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALB—ulcerative colitis	4.93e-06	3.26e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ABCB1—ulcerative colitis	4.86e-06	3.22e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ADCY5—ulcerative colitis	4.53e-06	3e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS2—ulcerative colitis	4.31e-06	2.86e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPARG—ulcerative colitis	3.38e-06	2.24e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALB—ulcerative colitis	3.04e-06	2.01e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS2—ulcerative colitis	2.66e-06	1.76e-05	CbGpPWpGaD
